- HealthStream Inc HSTM posted Q2 EPS of $0.08, beating the $(0.03) consensus but fell 27% Y/Y.
- Sales increased 7% Y/Y to $64.8 million, surpassing the consensus of $61.8 million.
- Revenues from the Workforce Solutions segment were $52.2 million, increasing 7% Y/Y. Sales from recent acquisitions and growth in other solutions more than offset the lost legacy resuscitation revenues.
- Revenues from the Provider Solutions segment were $12.7 million compared to $11.7 million a year ago, primarily attributable to subscription revenues.
- Operating margin contracted from 7.1% to 5.3% due to higher operating expenses and amortization, primarily associated with businesses acquired over the past year.
- Net income fell 29% to $2.4 million, while adjusted EBITDA improved from $12.1 million to $14.5 million. The cash balance stood at $55.1 million.
- FY21 Guidance: HealthStream raised its sales guidance to $253 million - $257 million from $245 million to 255 million, higher than the $251.3 million consensus.
- It expects adjusted EBITDA of $48 million - $50 million, compared to the earlier outlook of $40 million - $44 million.
- Price Action: HSTM shares closed at $29.43 on Monday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in